COVID-19 Conversations: Practical Concerns- Prognostication, Communication, Public Health Advocacy

The provision of hospice and palliative care has been significantly impacted by the COVID-19 pandemic. This video recording delivers information regarding the challenges of prognostication, communication, and public health measures around COVID-19. 

The current environment has been assessed for gaps in resources and competence and prioritized the needs for clinicians.  The faculty represent respected subject matter experts who share evidence and best practices in these areas. Listen in as the experts engage in a moderated discussion with the learners.

Disclaimer: Any recommendations made by the authors of this activity must be weighed against the healthcare clinician’s own clinical judgement based on but not limited to such factors as the patient’s condition, benefits verse risks of suggested treatment, and comparison with recommendations of pharmaceutical compendia and other medical and palliative care authorities.

Learning Objectives

  1. Discuss latest evidence and recommendations for prognostication, communication, and public health measures for delivering hospice and palliative care in the midst of the COVID-19 pandemic.
  2. Identify at least one strategy related to prognostication, communication, and/or public health measures that they can implement in their practice in the next month.
Activity summary
Available credit: 
  • 1.00 CME (physician only)
  • 1.00 Participation
Activity Published: 
06/01/2021
Activity Expires: 
06/01/2024
Member cost:
$0.00
List Price:
$39.00
Rating: 
0

Rachelle E. Bernacki, MD MS FAAHPM 
Holly B. Yang, MD HMDC FACP FAAHPM 
J. Randall Curtis, MD MPH

AAHPM endorses the standards of the Accreditation Council for Continuing Medical Education (ACCME). All who are in a position to control or influence the content of an educational activity must disclose all relevant financial relationships with an ineligible companies that they have had over the past 24 months. *Disclosures documents were reviewed for potential conflicts of interest and, if identified, they were mitigated prior to confirmation of participation. Only those who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this activity.

(All planners, faculty and staff have disclosed no relevant financial relationships.)

*An ineligible company is defined as those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients. Eligible companies are those whose mission and function are 1. providing clinical services directly to patients; or 2. The education of healthcare professionals, or 3. Serving as fiduciary to patients, the public, or population health; and other organizations that are not otherwise ineligible. (Examples of such organizations include: ambulatory procedure centers, blood banks, diagnostic labs that do not sell proprietary products, electronic health record companies, government or military agencies, group medical practices, health law firms, health profession membership organizations, hospitals or healthcare delivery systems, infusion centers, insurance or managed care companies, nursing homes, pharmacies that do not manufacture proprietary compounds, publishing or education companies, rehabilitation centers, schools of medicine or health science universities, or software, or software or game developers.)

 

 

Continuing Medical Education Credit

AAHPM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

AAHPM designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

CME Credits expire on June 1, 2024.

Available Credit

  • 1.00 CME (physician only)
  • 1.00 Participation

Price

Member cost:
$0.00
List Price:
$39.00
Please login or register to take this course.